Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.
Maarten J Deenen
,
Annemieke Cats
,
Jos H Beijnen
,
Jan H M Schellens
More about this publication
Therapeutic advances in medical oncology
Volume
5
Issue nr.
1
Pages
91-2
Publication date
01-01-2013
Full text links
Publisher website (DOI)
10.1177/1758834012464806
Europe PubMed Central
23323150
Pubmed
23323150